EBA
ABMD

Eagle Bay Advisors’s Abiomed Inc ABMD Stock Holding History

Eagle Bay Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-792
Closed -$196K – 1030
2022
Q3 		$196K Buy
792
+562
+244% +$152K 0.12% 126
2022
Q2 		$56.9K Buy
+230
New +$62.1K 0.03% 333
2022
Q1 		– Sell
-230
Closed -$83K – 1048
2021
Q4 		$83K Sell
230
-230
-50% -$77.7K 0.05% 227
2021
Q3 		$150K Buy
460
+230
+100% +$77.9K 0.08% 164
2021
Q2 		$72K Buy
+230
New +$70.6K 0.06% 221

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Eagle Bay Advisors's ABMD Position: Q4 2022 in Review

Eagle Bay Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 792 shares — an estimated $196K sold.

Eagle Bay Advisors first reported a position in ABMD in Q2 2021 and held it in 5 quarters. The position peaked at $196K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Eagle Bay Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Eagle Bay Advisors sold 792 Abiomed Inc shares in Q4 2022, an estimated $196K.
  • Eagle Bay Advisors first reported a position in Abiomed Inc in Q2 2021 and held it in 5 quarters.
  • Eagle Bay Advisors's Abiomed Inc position peaked at $196K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Eagle Bay Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.